Screening and Prostate-Cancer Mortality in a Randomized European Study

20093,992 citationsJournal Articlegreen Open Access

Authors

Fritz H. Schröder · Erasmus MC

Jonas Hugosson · Sahlgrenska University Hospital

Monique J. Roobol · Erasmus MC

Teuvo L.J. Tammela · Tampere University

Stefano Ciatto

Vera Nelen · Provincial Institute for Hygiene

Maciej Kwiatkowski · Kantonsspital Aarau

Abstract

PSA-based screening reduced the rate of death from prostate cancer by 20% but was associated with a high risk of overdiagnosis. (Current Controlled Trials number, ISRCTN49127736.)

Topics & Keywords

Prostate Cancer Diagnosis and Treatment Colorectal Cancer Screening and Detection Prostate Cancer Treatment and Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 360, Issue 13, pp. 1320-1328

DOI: 10.1056/nejmoa0810084

Field-Weighted Citation Impact: 403.40